Efficacy of risperidone, olanzapine and clozapine in the treatment of therapy resistant schizophrenia

Acta Neuropsychiatrica

Volumn 12, Issue 4, 2000, Pages 183-192

  Wardenier, M ^a   Slooff, C J ^a   Arends, J ^a  

^a Psychosencluster   (Netherlands)

Author keywords

Clozapine; New antipsychotics; Olanzapine; Positive symptoms; Risperidone; Therapy resistance

Indexed keywords

BENZATROPINE MESILATE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; RISPERIDONE;

ADULT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0033639089     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0924270800035365     Document Type: Review

References (34)

1. Natural course of schizophrenic disorders. A 15-year follow-up of a Dutch incidence cohort
2. Clozapine for treatment resistant schizophrenia: A double blind comparison with chloropromazine
3. The evolution of treatment resistance: Biologic implications
4. Dimensions of outcome with clozapine
5. Richtlijnen en standaarden: Een aanzet tot protocollering
6. Some adverse effects of antipsychotics: Prevention and treatment
7. Treatment of the refractory schizophrenic patient
8. The use of atypical antipsychotics in the management of schizophrenia
9. Risperidone in the treatment of schizophrenia
10. Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: Methodological issues and clinical consequences
11. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizofreniform disorders: Results of an international collaborative trial
12. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
13. Risperidone versus olanzapine in patients with schizophrenia and schizoaffective disorder
14. A comparative effective study of risperidone and olanzapine in the treatment of schizophrenia
15. Selecting an atypical antipsychotic by combining clinical experiences with guidelines from clinical trials
16. Risperidone in treatment-refractory schizophrenia
17. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia
18. An investigation of subgroup effects in a study of olanzapine versus clozapine in the treatment of resistant schizophrenic patients
19. An efficacy of risperidone in reducing positive and negative symptoms in medication-refractory schizophrenia: An open prospective study
20. Risperidone versus haloperiodol in the treatment of chronic schizophrenic inpatients: A multicentre double-blind comparative study
21. Efficacy of risperidone on positive features of schizophrenia
22. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia
23. Randomized, double blind controlled trial of risperidone versus clozapine in patients with chronic schizophrenia
24. Clozapine and risperidone in chronic schizophrenia: Effects on symptoms, parkinsonian side effects, and neuroendocrine response
25. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: A randomized double-blind study
26. Switching from clozapine to olanzapine in treatment-refractory schizophrenia: Safety, clinical efficacy, and predictors of response
27. Is olanzapine a substitute for clozapine? The effects on psychomotor performance: Proceedings of the 10th Biennial Winterworkshop on schizophrenia; 2000, Feb 6-11.; Davos, Switzerland
28. Clozapine in the treatment of 121 out-patients
29. Risperidone and clozapine combination for the treatment of refractory schizophrenia
30. Risperidone augmentation of clozapine